Subscibe to DEAL OF THE DAY

Diabetic Digest - November 8, 2017


I've been concerned about my last A1C test. I remember my doctor telling me that it was 7.5 three months ago. He said that it could be better and he's right. So over the last few months I've made changes to my diet and tried to exercise more than I have in a long while. I hope things improve.

My next A1C test is scheduled for this evening. I won't know the results for a few days, but I'll be sure to let you know how things turned out in the next issue. I know, what a cliffhanger! Wish me luck!

Until next time, please read the article I found concerning a new oral diabetes drug shows promise for type 1 patients, and I have a great recipe for Cheesy Frosted Cauliflower. Food for the mind and for the body. Good stuff!


P.S. Did you miss an issue? You can read every issue from the Gophercentral library of newsletters on our exhaustive archives page. Thousands of issues, all of your favorite publications in chronological order. You can read AND comment. Just click GopherArchives

Comments? Questions? Email Steve

*-- Diabetic News --*

New oral diabetes drug shows promise for type 1 patients

A Phase 3 clinical trial of the drug, sotagliflozin, show promise at helping to control glucose levels and reduce the need for insulin in type 1 diabetics.

Preliminary results of the trial by the University of Colorado Anschutz Medical Campus were published today in the New England Journal of Medicine.

Sotagliflozin is an investigational new oral drug for patients with type 1 diabetes to improve glucose control without any increase in severe hypoglycemia, or low blood sugar, or diabetic ketoacidosis compared to insulin alone.

Researchers found that of the 1,402 trial participants given sotagliflozin, the drug showed clinically meaningful and statistically significant effects on glucose control with improved A1C numbers compared to placebo after 24 weeks of treatment. Most patients struggle to achieve optimal blood glucose control with just insulin alone.

"Sotagliflozin added to insulin therapy can potentially help patients with type 1 diabetes improve their glucose control and hopefully manage the disease with fewer complications," Dr. Satish Garg, professor of medicine and pediatrics at the Barbara Davis Center for Diabetes at the Anschutz Medical Campus, said in a press release. "This would not be a replacement for insulin; it is an adjunctive therapy. However, because it works in the gut and the kidneys, it doesn't require insulin to have an effect."

Sotagliflozin would be used in conjunction with insulin and researchers found that participants taking the drug orally along with traditional insulin treatments had significant improvements in glucose control, a drop in systolic and diastolic blood pressure and weight loss.

"Sotagliflozin may reduce the bad effects of insulin and the dose patients need," Garg said. "Patients in our study had lower weights, no severe hypoglycemia and better blood pressure."

*-- Diabetic News --*


1 med head cauliflower (take note of weight when purchased)
1/4-1/2 cup mayonnaise (low fat if desired)
1/4 teaspoon salt (optional)
1-2 teaspoon prepared mustard
1/4 cup grated cheddar cheese

Remove woody base of cauliflower, leaving cauliflower in whole head. Pierce the core with a knife to make porous. Place in 2 quart microwave casserole and cook, covered, for 6 minutes per pound on High power (100%). Let stand a few minutes. Salt if desired. Spread cauliflower with mixture of mayonnaise and mustard. Sprinkle with cheese. Heat for 1 minute, or until cheese melts, on Medium-high power (70%). Sprinkle with paprika, slice into wedges and serve immediately.

Categories: Vegetables


Missed an Issue? Visit the Diabetic Digest Archives